Life Tech, RainTree Oncology Collaborate to Advance Molecular Testing | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies and RainTree Oncology Services today announced a collaborative agreement to bring advances in molecular testing to the broader patient market while developing a streamlined protocol for bringing patients into clinical trials for targeted therapies.

Through the deal, Life Tech intends to participate in developing next-generation sequencing panels for the deep interrogation of tumors. Other assays may also be developed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.